Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer exec Stephen Williams joins Venaxis board

Is current chief medical officer of SomaLogic

Former Pfizer exec Stephen Williams joins Venaxis boardVenaxis has appointed former Pfizer VP Dr Stephen Williams to its board of directors.

Dr Williams, who is currently chief medical officer at SomaLogic, has years of experience in diagnostic imaging and biomarker discovery, which will benefit Venaxis as it prepares to clear and commercialise its protein biomarker-based assay for appendicitis.

Dr Williams said: "The APPY1 Test is an excellent example of how characterisation of clinically relevant biomarkers can produce useful tools for addressing important diagnostic challenges.

“With the potential to reduce the safety risks associated with current diagnostic imaging techniques in the emergency setting, I believe there is significant clinical need and utility for the APPY1 Test.”

Dr Williams joined SomaLogic in 2009, leading the development of its protein biomarkers and clinical diagnostics.

He joined Pfizer in 1989, and spent 18 years at the company, working in both the UK and US and holding roles that included worldwide head, clinical technology.

In addition, Dr Williams served on the National Advisory Council for the National Institute of Biomedical Imaging and Bioengineering from 2004 to 2007 and the executive Committee of the Biomarkers Consortium run by the Foundation for NIH from 2005-2007.

23rd April 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics